Compare CLLS & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | CRMT |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 266.5M |
| IPO Year | 2007 | N/A |
| Metric | CLLS | CRMT |
|---|---|---|
| Price | $4.98 | $21.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $8.00 | ★ $45.00 |
| AVG Volume (30 Days) | 124.5K | ★ 169.0K |
| Earning Date | 11-07-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.61 |
| Revenue | $82,551,000.00 | ★ $1,378,681,000.00 |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | $58.00 | $5.72 |
| P/E Ratio | ★ N/A | $13.42 |
| Revenue Growth | ★ 129.04 | 0.64 |
| 52 Week Low | $1.10 | $17.78 |
| 52 Week High | $5.48 | $62.72 |
| Indicator | CLLS | CRMT |
|---|---|---|
| Relative Strength Index (RSI) | 69.02 | 49.05 |
| Support Level | $4.90 | $17.78 |
| Resistance Level | $5.35 | $19.95 |
| Average True Range (ATR) | 0.28 | 1.22 |
| MACD | 0.14 | 0.75 |
| Stochastic Oscillator | 85.56 | 67.46 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.